Home > Boards > US Listed > Biotechs > Akari Therapeutics (AKTX)

New york office my friend! 646-350-0702

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
makingbiigdough Member Profile
 
Followed By 121
Posts 4,708
Boards Moderated 1
Alias Born 10/20/01
160x600 placeholder
Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study GlobeNewswire Inc. - 1/10/2020 9:30:09 AM
Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Pediatric Hematopoietic Stem Cell Transpla... GlobeNewswire Inc. - 12/23/2019 8:45:10 AM
Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Rela... GlobeNewswire Inc. - 12/2/2019 8:30:10 AM
Akari Therapeutics Reports Third Quarter 2019 Financial Results And Highlights Recent Clinical Progress GlobeNewswire Inc. - 11/4/2019 8:33:48 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/28/2019 6:01:19 AM
Securities Registration (foreign Private Issuer) (f-1) Edgar (US Regulatory) - 10/15/2019 5:24:28 PM
Securities Registration (ads, Immediate) (f-6ef) Edgar (US Regulatory) - 10/15/2019 5:09:46 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/15/2019 7:08:47 AM
Akari Therapeutics Announces New Data from Atopic Keratoconjunctivitis (AKC) Patients Supporting the Potentially Beneficial R... GlobeNewswire Inc. - 10/14/2019 8:37:28 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/10/2019 9:03:34 AM
Akari Therapeutics Announces Positive Phase II Clinical Data in Orphan Blistering Skin Disease Bullous Pemphigoid at the 28th... GlobeNewswire Inc. - 10/10/2019 8:45:02 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/4/2019 4:48:17 PM
Akari Therapeutics to Participate in Ladenburg Thalmann Healthcare Conference GlobeNewswire Inc. - 9/18/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/13/2019 8:17:32 AM
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Bullous Pemphigoid GlobeNewswire Inc. - 9/13/2019 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/10/2019 8:22:04 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/9/2019 6:01:20 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/6/2019 5:08:04 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/6/2019 6:01:28 AM
Akari Therapeutics to Participate in Citi and H.C. Wainwright Conferences in Early September GlobeNewswire Inc. - 9/3/2019 7:00:00 AM
Securities Registration (foreign Private Issuer) (f-1/a) Edgar (US Regulatory) - 8/30/2019 4:04:38 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 8/30/2019 4:02:20 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/30/2019 8:13:13 AM
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated T... GlobeNewswire Inc. - 8/30/2019 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/29/2019 8:29:12 AM
makingbiigdough   Thursday, 08/16/18 03:51:16 PM
Re: BrazenBull post# 205
Post # of 481 
New york office my friend! 646-350-0702
IR: Peter Vozzo is an idiot!!! NEEDS TO BE FIRED!!!! Never returns phone calls!!! IR 443-213-0505

Put in a call today myself! If I hear anything I'll let you know please do the same . Can't wait for this to run so I can come out to the BBC for a MUCH needed vacation!!! LOL MBD

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist